Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Kroo Bank Ltd, a fully licensed UK bank, began with a bold vision to be the first bank that people trust and genuinely enjoy. Offering current accounts and personal loans, the company has successfully opened 145,000 current accounts and accumulated £765 million in deposits, achieving this with an average customer acquisition cost of £38. Kroo's revenue model hinges on transaction fees and net interest margins from both deposits and loans, ensuring efficient and cost-effective customer acquisition. Looking ahead, the company has exciting plans to expand its product range, introduce new features, and expand its personal loan services.
days to go:
Expired
investment:
£2,010,954
Nova launches growth focus, tech-enabled startups, putting passionate founders at the heart of everything they do. It creates a more rewarding experience for startups with its co-founding model. The company conceives and scales digital businesses thereby solving the real-world problems, open new markets and disrupt existing ones. 46% of Nova co-founded businesses are still trading. There are 140+ staff over Manchester, Liverpool, London, and Islamabad. There is a 3% portfolio valuation growth YOY, thereby creating more than £72m valuation of the portfolio. The company made a turnover of £7.2m in 2018/19. Nova is raising funds to leverage the company's growing network of Founders, Funds, and Talent in the UK.
days to go:
Expired
investment:
£744,880
Lime Global is a UK-based company dedicated to becoming the most customer-focused provider of health cover. Lime argues that conventional health insurance is too expensive and overly complicated. It intends to make health insurance affordable allowing customers to buy the top-ups they want without consulting advisers or filling long questionnaires. Lime Global claims to provide customers with a cancer cover providing a lump sum and support following diagnosis, access to 'Rapid Diagnostics' to avail private diagnostic tests, and an online platform where customers and employers can book and pay for clinical services. Lime Global aspires to become a contender in the UK private healthcare market set to grow more than £8 billion. The company points out that it has secured 5 star Trustpilot reviews over the last year with zero complaints to date. They intend to use the investment to support their expansion into Small and Medium Enterprises (SMEs), mental health modules and e-pharmacies, scale customer acquisition, and support the next stage of its growth in late 2021 and early 2022.
days to go:
Expired
investment:
£474,838
Prosper is creating a customer-focused brand, aiming to offer free access to public and private funds, competitive cash rates, and instant financial advice via a mobile app. They charge a platform fee based on the customer's assets. The experienced team behind successful ventures like Tandem Bank and Nutmeg is targeting the UK's expensive and underperforming savings and investment market. They've raised £3.2 million from investors including Tom Blomfield (Monzo) and Charlie Delingpole (ComplyAdvantage).
days to go:
Expired
investment:
£1,022,665
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
